Classes
Publications
- Tau protein, phospohorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits +12009 | Faculty of Medicine in Hradec Králové
- Tau Protein, Phosphorylated Tau Protein and Beta-Amyloid42 in the Cerebrospinal Fluid of Multiple Sclerosis Patients +12008 | Faculty of Medicine in Hradec Králové
- The role of proportion of cerebroepinal fluid total tau-protein levels to phosphorylated tau protein levels in differential of Demencia +12008 | Faculty of Medicine in Hradec Králové
- Total and Phosphorylated Tau-protein and Beta-Amyloid 42 in Cerebrospinal Fluid in Dementias and Multiple Sclerosis2008 | Faculty of Medicine in Hradec Králové
- Fingolimod treatment of multiple sclerosis at any age2022 | Faculty of Medicine in Pilsen
- Glatirameracetate - the treatment of multiple sclerosis monitored in the ReMuS Registry2020 | Faculty of Medicine in Pilsen
- Escalation of multiple sclerosis treatment in children2020 | Faculty of Medicine in Pilsen
- Commentary : Okrelizumab - benefits of five years of treatment2020 | Faculty of Medicine in Pilsen
- Multiple sclerosis in children and adolescents and new therapeutic options2019 | Faculty of Medicine in Pilsen
- Treatment possiblities of multiple sclerosis in children and adolescents2019 | Faculty of Medicine in Pilsen
Loading network view...